Histoplasmosis as a Complication of Inflammatory Bowel Disease Therapy: A Case Series
Inflamm Bowel Dis
.
2019 May 4;25(6):e69-e70.
doi: 10.1093/ibd/izy372.
Authors
Baldeep S Pabla
1
,
Elizabeth A Scoville
1
,
Shabnam Sarker
1
,
Robin L Dalal
1
,
Sara N Horst
1
,
David A Schwartz
1
,
Dawn B Beaulieu
1
Affiliation
1
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
PMID:
30544149
PMCID:
PMC7327270
DOI:
10.1093/ibd/izy372
No abstract available
Publication types
Letter
MeSH terms
Antifungal Agents / therapeutic use
Female
Histoplasmosis / drug therapy
Histoplasmosis / etiology*
Humans
Inflammatory Bowel Diseases / complications*
Male
Prognosis
Retrospective Studies
Substances
Antifungal Agents
Grants and funding
KL2 TR002245/TR/NCATS NIH HHS/United States